Is There a Role for Levothyroxine Therapy in Euthyroid Patients on Active Surveillance for Papillary Microcarcinoma?

ThyroidVol. 33, No. 10 CommentariesIs There a Role for Levothyroxine Therapy in Euthyroid Patients on Active Surveillance for Papillary Microcarcinoma?R. Michael TuttleR. Michael TuttleAddress correspondence to: R. Michael Tuttle, MD, Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA E-mail Address: [email protected]Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.Search for more papers by this authorPublished Online:13 Oct 2023https://doi.org/10.1089/thy.2023.0424AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 33Issue 10Oct 2023 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:R. Michael Tuttle.Is There a Role for Levothyroxine Therapy in Euthyroid Patients on Active Surveillance for Papillary Microcarcinoma?.Thyroid®.Oct 2023.1137-1139.http://doi.org/10.1089/thy.2023.0424Published in Volume: 33 Issue 10: October 13, 2023Online Ahead of Print:September 11, 2023Online Ahead of Editing: August 19, 2023PDF download